```html

White Spot Disease (Nail Fungus)

Overview

White spot disease—also known as onychomycosis when it involves the nails—is a fungal infection that produces white, powder‑y or chalky patches on the nail plate. The condition most often affects toenails, but fingernails can be involved as well. It is caused by dermatophyte, non‑dermatophyte molds, or yeasts that invade the keratin of the nail.

Globally, nail fungus is one of the most common dermatologic conditions. The U.S. Centers for Disease Control and Prevention (CDC) estimates that up to 10 % of the population will experience nail fungus at some point in their lives, with prevalence increasing to 20 %‑30 % among people over 60 years old. Women are slightly more affected than men, likely because of narrower shoe widths and higher rates of cosmetic nail care.

Symptoms

The appearance of white spot disease can vary from a few tiny specks to extensive nail involvement. Common signs include:

• White, powdery or chalky spots on the nail surface—often the earliest sign.
• Thickening of the nail as the infection spreads deeper into the nail bed.
• Discoloration—the nail may become yellow, brown, or gray in addition to the white patches.
• Loss of nail translucency making the nail look opaque.
• Raised or ragged nail edges that may crumble or split (onycholysis).
• Distorted nail shape—the nail can become cupped or deformed.
• Odor—a mild, unpleasant smell can develop as the fungus proliferates.
• Pain or tenderness—usually only when the infection is advanced or if secondary bacterial infection occurs.

Symptoms typically progress slowly over months, which is why many people overlook early white spots.

Causes and Risk Factors

What causes white spot disease?

The disease results from the invasion of the nail plate by fungi that thrive in warm, moist environments:

• Dermatophytes – most common species: Trichophyton rubrum, T. interdigitale, and Epidermophyton floccosum.
• Yeasts – especially Candida albicans, more common in fingernail infections.
• Non‑dermatophyte molds – e.g., Scopulariopsis brevicaulis, usually seen in people with immune compromise.

Who is at higher risk?

• Age > 60 years (reduced nail growth rate and circulation).
• People with peripheral vascular disease, diabetes, or immunosuppression.
• Individuals who wear tight, non‑breathable footwear or spend long periods barefoot in communal areas (pools, gyms, showers).
• History of athlete’s foot or other skin fungal infections.
• Trauma to the nail (e.g., stubbing, repeated pressure).
• Frequent use of nail cosmetics, artificial nail extensions, or harsh nail polish removers.
• Occupations with constant exposure to water or moist environments (e.g., healthcare workers, chefs).

Diagnosis

Because early white spots can mimic other nail problems (psoriasis, eczema, trauma), accurate diagnosis is essential.

Clinical examination

Dermatologists or podiatrists will inspect the nail, looking for characteristic white macules, subungual hyperkeratosis, and nail plate changes. A Wood’s lamp (UV light) may accentuate fungal fluorescence, but it is not definitive.

Laboratory tests

1. KOH (potassium hydroxide) preparation – a scrap of nail is placed on a slide with KOH solution; under a microscope, fungal hyphae become visible within minutes. Sensitivity is ~70 %.
2. Fungal culture – the nail sample is placed on a special medium and incubated for 2‑4 weeks. Though time‑consuming, it identifies the specific organism, guiding therapy.
3. PCR (polymerase chain reaction) testing – increasingly used in specialized labs; it detects fungal DNA rapidly and with higher sensitivity.
4. Histopathology – a nail biopsy stained with periodic acid‑Schiff (PAS) can confirm infection when other tests are inconclusive.

Guidelines from the CDC and Mayo Clinic recommend confirming the diagnosis before initiating systemic antifungal therapy, because oral agents have potential side effects.

Treatment Options

Treatment selection depends on disease extent, patient comorbidities, and personal preference. Options range from topical agents for mild disease to oral systemic therapy for extensive infection.

Topical antifungals

• Efinaconazole 10 % solution (Jublia) – applied daily for 48 weeks; cure rates ~15‑18 % in clinical trials (Mayo Clinic, 2020).
• Tavaborole 5 % solution (Kerydin) – similar efficacy to efinaconazole with a slightly shorter treatment course.
• Ciclopirox 8 % lacquer (Penlac) – less effective (cure rates <10 %); often used as adjunct therapy.

Topicals are safest (minimal systemic absorption) but require strict daily application for up to a year.

Oral systemic antifungals

• Terbinafine 250 mg daily for 6‑12 weeks (toenails) or 12 weeks (fingernails). Cure rates 70‑80 % (Cleveland Clinic, 2021). Requires baseline liver function tests (LFTs) and monitoring every 4‑6 weeks.
• Itraconazole pulse therapy – 200 mg twice daily for 1 week per month, repeated 2‑3 months (toenails) or 1 month (fingernails). Useful for patients with drug interactions that preclude terbinafine.
• Fluconazole – 150‑300 mg weekly for 12‑24 weeks; an alternative when terbinafine is contraindicated.

Systemic agents have higher cure rates but can affect liver enzymes, interact with other medications, and may cause taste disturbances or rash.

Procedural interventions

• Laser therapy – 1064 nm Nd:YAG laser destroys fungal elements; evidence is mixed, and it is often combined with topical agents.
• Photodynamic therapy (PDT) – photosensitizer applied to nail, activated with light; experimental but promising in small trials.
• Surgical nail removal – considered for severe onycholysis or when rapid cosmetic improvement is desired. The nail regrows over 6‑12 months, during which antifungal treatment continues.

Adjunctive lifestyle measures

• Keep feet dry; change socks at least once daily.
• Trim nails straight across, file down thickened areas.
• Avoid artificial nails until infection resolves.
• Use antifungal powders or sprays in shoes.

Living with White Spot Disease (Nail Fungus)

Even after successful treatment, nails grow slowly (≈1 mm per month for toenails). Patience and good nail hygiene are essential.

• Daily foot care – wash with mild soap, dry thoroughly, especially between toes.
• Footwear choice – wear breathable shoes (leather, mesh) and rotate pairs to allow drying.
• Moisture control – apply talc or antifungal powder to socks and shoes.
• Protective barriers – use silicone or cotton socks in communal showers.
• Monitor regrowth – take photos monthly to track nail improvement; report any new white spots to your clinician.
• Limit nail cosmetics – avoid dark nail polish that can hide early recurrence.

Prevention

Preventive steps focus on reducing fungal exposure and maintaining nail health:

• Wear flip‑flops in public lockers, pools, and showers.
• Choose moisture‑wicking socks (e.g., wool or synthetic blends) rather than cotton.
• Disinfect nail clippers after each use with 70 % isopropyl alcohol.
• Avoid sharing nail tools, towels, or shoes.
• Keep cuticles trimmed but intact; over‑trimming can create entry points.
• For diabetic or immunocompromised patients, schedule regular podiatry check‑ups.
• Consider prophylactic antifungal spray in shoes if you have a history of recurrent infections.

Complications

If left untreated, white spot disease can lead to several problems:

• Onycholysis – separation of the nail from the nail bed, increasing infection risk.
• Secondary bacterial infection – can cause cellulitis, especially in diabetics.
• Permanent nail deformity – thickened, discolored, or dystrophic nail that may never return to normal appearance.
• Pain and functional limitation – especially with toenail involvement causing difficulty walking or wearing shoes.
• Spread to other nails or skin – leading to widespread dermatophytosis.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. Nail Fungus (Onychomycosis). Updated 2023.
• Mayo Clinic. Nail Fungus Diagnosis and Treatment. 2022.
• Cleveland Clinic. Onychomycosis (Nail Fungus). 2021.
• World Health Organization. Fungal Diseases Fact Sheet. 2022.
• British Association of Dermatologists. Patient Information Leaflet: Nail Fungus. 2020.
• Liu, Y. et al. “Efficacy of oral terbinafine versus itraconazole in the treatment of onychomycosis: a systematic review.” *Journal of the American Academy of Dermatology*, 2021.

```